NWPF

News ArchivesRead News

Exercise Protects Against Parkinson's

Thursday October 22, 2009

Society for Neuroscience - Long-term exercise protects against the loss of dopamine-producing cells and energy-producing mitochondria in neurons, which are important for maintaining function and movement in a chronic mouse model of Parkinson's disease, a new study reports.

These results, report at the Neuroscience 2009 Show in Chicago, support the concept that exercise may slow the progression of Parkinson's disease.

"Clinical reports have implicated exercise training in improving the physical performance and mobility of people with Parkinson's disease, but no one has demonstrated, either clinically or in laboratory models, whether exercise can delay the progression of neuronal degeneration," says senior author Yuen-Sum Lau at the Univ. of Houston. "This study was aimed at investigating this possibility and at examining how exercise protects neural mitochondria."

In people with Parkinson's disease, mitochondria-the energy factory of cells-become sluggish, which contributes to the death of dopamine neurons in brain areas that control motor functions. The loss of dopamine neurons is believed to trigger the symptoms of Parkinson's disease.

The mice used in the study were chronically induced with a neurotoxin to have many features that resemble human Parkinson's disease, including impaired movement and a marked loss of brain dopamine and mitochondrial function. The animals were divided into two groups: one was kept sedentary; the other exercised on a motorized treadmill for 40 minutes daily, five days a week, for 18 weeks. At the end of the study, the exercise-trained Parkinson's mice had significantly higher brain dopamine content and exhibited greater brain mitochondrial activity than the sedentary mice. They also performed better in a test that assessed their balancing abilities.

"This research provides scientific evidence that long-term endurance exercise protects brain mitochondria and dopamine-producing neurons from undergoing progressive degeneration as demonstrated in the chronic mice model of Parkinson's disease," says Lau.

Their research was supported by the NIH's National Institute of Neurological Diseases and Stroke.

Recent News

Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement